CME to Sue CFTC Over 50-to-1 Perpetual Futures Approval
Updated
Updated · Reuters · Jun 17
CME to Sue CFTC Over 50-to-1 Perpetual Futures Approval
3 articles · Updated · Reuters · Jun 17
Summary
CME said it will file suit on Thursday against the CFTC over its approval of perpetual futures, after CEO Terry Duffy told CNBC the exchange operator was ready for a legal fight.
50-to-1 leverage and automatic liquidation models are central to CME's challenge: Duffy says the products threaten retail investors and that the regulator rushed approval without a full review of a novel instrument.
Coinbase and Kalshi won the CFTC's approval last month to launch perpetual crypto futures, the first such contracts available to U.S. investors on domestic regulated exchanges.
CFTC called the case frivolous and said it expects dismissal, while the approval had already knocked shares of CME, Cboe and ICE on fears of a long-term competitive threat.
Is CME's lawsuit a defense of market integrity or a move to eliminate a disruptive rival?
As states sue over 'illegal betting,' can federal regulators truly control perpetual futures?
With RWA perpetuals booming, is Wall Street's old guard losing control of financial innovation?
CME Group vs. CFTC: The High-Stakes Lawsuit Over U.S. Bitcoin Perpetual Futures Approval
Overview
In June 2026, the CME Group filed a lawsuit against the U.S. Commodity Futures Trading Commission (CFTC) after the CFTC approved the first regulated Bitcoin perpetual futures contract in the United States. This decision, which followed months of planning by CME’s board, sparked immediate tension in the U.S. derivatives market. The launch of the first regulated Bitcoin perpetual futures by KalshiEX highlighted the shift, as traditional exchanges like CME faced new competition. The legal battle now centers on how these innovative crypto products should be classified and regulated, with the outcome set to shape the future of digital asset derivatives in the U.S.